Sign in

CIK 0001770121

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sana Biotechnology, Inc.

Sign in to watch
Ticker
SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831381173
Phone
+1 206-701-7914
Business address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2025-06-05 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2024-06-06 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2024-06-06 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +54,278 54,278
2024-02-08 NELSEN ROBERT Director Purchase +363,637 $5.50 $2.0M 10,667,387
2024-02-08 NELSEN ROBERT Director Purchase +727,272 $5.50 $4.0M 12,446,022
2024-02-08 NELSEN ROBERT Director Purchase +727,272 $5.50 $4.0M 12,446,022
2023-06-08 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2023-01-05 NELSEN ROBERT Director Grant or award +536 1,353
2022-10-05 NELSEN ROBERT Director Grant or award +321 817
2022-07-05 NELSEN ROBERT Director Grant or award +266 496
2022-06-06 NELSEN ROBERT Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2022-04-05 NELSEN ROBERT Director Grant or award +230 230
2021-04-21 NELSEN ROBERT Director Other acquisition +12,500 12,500
2021-02-08 NELSEN ROBERT Director Conversion +10,156,250 10,303,750
2021-02-08 NELSEN ROBERT Director Conversion +10,156,250 10,301,250
2021-02-08 NELSEN ROBERT Director Conversion +11,718,750 11,718,750
2021-02-08 NELSEN ROBERT Director Conversion +11,718,750 11,718,750
2021-02-08 NELSEN ROBERT Director Conversion · Series A-1 Convertible Preferred Stock −3,687,500 0
2021-02-08 NELSEN ROBERT Director Conversion · Series A-1 Convertible Preferred Stock −3,687,500 0

Page 1 of 2 · 30 trades